ISO An Introduction. Alice Ravizza
|
|
- Olivia Harrison
- 6 years ago
- Views:
Transcription
1 ISO An Intrductin Alice Ravizza
2 Legal framewrk The regulatry requirements include: Demnstratin f safety Demnstratin f efficacy Psitive balance f risk and benefit The regulatry requirements can be met by means f Cmpliance t internatinal nrms (ISO, AAMI) Pre-validated testing
3 Prject teamwrk Prject leader Define prttype status Apprve test results Regulatry expert Identify minimum required testing Engineer Prvide manufacturing methds Prvide prduct specificatins Bilgist and bitechnlgist Test prtcl Testing Test results cmment
4 ISO 10993: A FAMILY OF NORMS Scpe: all medical devices Aim: planning apprpriate testing t ensure safety f the materials and f the device Acceptance: recgnized wrld-wide, if applied by: certified labs (ISO r similar accreditatin) Accrding t Gd Labratry Practices
5 ISO 10993: structure 1/5 A series f nrms n planning Part 1: Evaluatin and testing within a risk management prcess: a main nrm fr Identificatin Planning Reprting Part 12: Sample preparatin and reference materials: a general nrm n GLP
6 ISO 10993: structure 2/5 A series f nrms n standard bicmpatibility testing: Part 3: Tests fr gentxicity, carcingenicity and reprductive txicity Part 4: Selectin f tests fr interactins with bld Part 5: Tests fr in vitr cyttxicity Part 6: Tests fr lcal effects after implantatin Part 10: Tests fr irritatin and skin sensitizatin Part 11: Tests fr systemic txicity Part 20: Principles and methds fr immuntxiclgy testing f medical devices (Technical Specificatin)
7 ISO 10993: structure 3/5 A series f nrms n leachables: Part 7: Ethylene xide sterilizatin residuals Part 16: Txickinetic study design fr degradatin prducts and leachables Part 17: Establishment f allwable limits fr leachable substances
8 ISO 10993: structure 4/5 A series f nrms n degradatin prducts: Part 9: Framewrk fr identificatin and quantificatin f ptential degradatin prducts Part 13: Identificatin and quantificatin f degradatin prducts frm plymeric medical devices Part 14: Identificatin and quantificatin f degradatin prducts frm ceramics Part 15: Identificatin and quantificatin f degradatin prducts frm metals and allys
9 ISO 10993: structure 5/5 A series f nrms n material identificatin methds: Part 18: Chemical characterizatin f materials Part 19: Physic-chemical, mrphlgical and tpgraphical characterizatin f materials (Technical Specificatin)
10 Nrm relevance Cmpliance f test methds t the methds described in the ISO series allws t avid test validatin Cmpliance f results t the limits set in the ISO series allws presumptin f safety SHORTCUT TO PROOF OF SAFETY
11 ISO fr Risk management Guidance fr the bilgical evaluatin within a risk management prcess, as part f the design f each device. prtectin f humans frm ptential bilgical risks arising frm the use f medical devices. cncerning the bilgical evaluatin f medical devices. Data frm: the review and evaluatin f existing data frm all surces with, the selectin and applicatin f additinal tests, Full evaluatin f the bilgical respnses t each medical device, relevant t its safety in use Determinatin f the effects n tissues, mstly in a general way, nt a specific device-type situatin
12 A risk- based apprach
13 ISO fr Test Planning Bilgical evaluatin is based n: Material and raw material identificatin data Data frm literature Testing Bilgical testing is based n: in vitr ex viv test methds animal mdels Aim: anticipate the behavir f a new device in humans BUT it cannt be unequivcally cncluded that the same tissue reactins will als ccur in humans differences in the respnse t the same material amng individuals: sme patients can have adverse reactins, even t well-established materials.
14 Ex viv and animal mdels Minimize the number and expsure f test animals Preference t chemical cnstituent testing and in vitr mdels, IF these methds yield equally relevant infrmatin Dedicated nrm: Part 2: Animal welfare requirements: a general nrm fr animal testing Applies t all animal mdels and all tests Integrated by lcal law
15 ISO : Cntents The risk based apprach Categrizatin f medical devices nature f bdy cntact duratin f cntact Bilgical evaluatin prcess Material and subprducts characterizatin Bilgical evaluatin tests Interpretatin f results Test planning (annex A and B) Literature review guidance (annex C)
16 The risk based apprach (annex B) Risk analysis based n knwn infrmatin Intended use Knwn materials Assess hazards Frm materials, additives, leachables Txiclgy data, dse-respnse rate Nature f expsure (time, path, ttal expsure ver the clinical life) Estimate risk On patient health Use past experience t estimate prbability f ccurrence Lwer risk where pssible Evaluate verall risk-benefit rati
17 CLASSIFICATION By nature f bdy cntact Surface (skin, mucse, breached surface) External path (indirect bld path ex IV sets, tissue as path ex laparscpes, bld circuits) Implant devices (tissue r bne, bld) By duratin f cntact A: Limited - 24h r less B: Prlnged 24h t 30 d C: Permanent 30d plus (even intermittent)
18 Befre testing Material characterizatin Chemical cnstituents Prcess residuals Cmbinatin f knwn raw materials REF: ISO and ISO/TS Leachables and degradatin prducts Impact f leachables frm materials and n materials REF: ISO Fr the acceptable level f leachables (risks arising frm txiclgically hazardus substances) Presence and nature f degradatin prducts REF: ISO , ISO , ISO , and ISO (identificatin f degradatin prduct in different materials)
19 Bilgical testing Only if n past data are available On the (sterile) final prduct, frm cmmercial manufacturing Test planning as per annex A Test prtcl t identify crrect prcedures VS psitive r negative cntrl Accrding t GLP and/r ISO The test results shuld be reprducible (intralabratry) as well as repeatable (interlabratry) and rbust.
20 Test planning Table A.1 Evaluatin tests fr cnsideratin Medical device categrizatin by Bilgical effect Categry nature f bdy cntact (see 5.2) Cntact cntact duratin (see 5.3) A limited (u 24 h) B prlnged (> 24 h t 30 d) C permanent (> 30 d) Cyttxicity Sensitizatin Irritatin r intracutaneus reactivity Systemic txicity (acute) Subchrnic txicity (subacute txicity) Gentxicity Implantatin Haemcmpatibility Surface device External cmmunicating device Implant device Mucsal membrane Breached r cmprmised surface Bld path, indirect Tissue/bne/dentin Circulating bld Tissue/bne Bld A X a X X B X X X C X X X A X X X B X X X C X X X X X A X X X B X X X C X X X X X A X X X X X B X X X X X C X X X X X X A X X X B X X X X X X X C X X X X X X X A X X X X X B X X X X X X X X C X X X X X X X X A X X X B X X X X X X X C X X X X X X X A X X X X X X X B X X X X X X X X C X X X X X X X X a The crsses indicate data endpints that can be necessary fr a bilgical safety evaluatin, based n a risk analysis. Where existing data are adequate, additinal testing is nt required.
21 Test verview 1/5 Cyttxicity (cell culture) -5 lysis f cells (cell death), inhibitin f cell grwth, clny frmatin Delayed-type hypersensitivity (rabbit) -10 estimate the ptential fr cntact sensitizatin NOTE: These tests are imprtant because expsure r cntact t even minute amunts f ptential leachables can result in allergic r sensitizatin reactins. NOTE: an in vitr test is validated nly fr pure chemicals and is under validatin fr devices NOTE: if any irritatin is expected, nly 1 animal is t be used: if this animal shws irritatin, n further testing is required and the device fails Irritatin(rabbit) -10 Fr external cntact devices: skin, eye and mucus membrane with apprpriate rute and time f cntact Fr implanted: intracutaneus reactivity test
22 Test verview 2/5 Systemic txicity (acute, subacute and subchrnic, chrnic) (muse, rat r rabbit)(frm 5 t 40 animals, fr 24h up t a majr amunt f the life span f the animal) -11 used where cntact allws ptential absrptin f txic leachables and degradatin Dermal. Implantatin, inalatin, intradermal, intramusclar, intraperitneal, intravenus, ral, subcutaneus Observatin f clinical signs n the mai phisilgical parameters (examples: dysphneas, slwer reflexes, bradicardia r tachicardia, ) Pyrgenicity tests are included. (N single test can differentiate pyrgenic reactins that are material-mediated frm thse due t endtxin cntaminatin). May be cmbined and may be extended fr implantatin testing Gentxicity (in vitr, mammalian cell cltures) -3 gene mutatins, changes in chrmsme structure and number, and ther DNA r gene txicities If any f the in vitr tests are psitive, either in viv mutagenicity tests shall be perfrmed r the presumptin shall be made that the material is mutagenic
23 Test verview 3/5 Implantatin (apprpriate animal mdel: ex. Rabbit fr bne) -6 Assess the lcal pathlgical effects n living tissue, at bth the grss level and micrscpic level, f a sample f a material r final prduct that is surgically implanted r placed in an implant site r tissue apprpriate t the intended applicatin These tests shall be apprpriate fr the rute and duratin f cntact. Haemcmpatibility (in vitr r bench) -4 Effects bld r bld cmpnents. haemlysis, determines the degree f red cell lysis and the release f haemglbin caused by medical devices, materials, and/r their extracts in vitr. Other specific haemcmpatibility tests may als be designed t simulate the gemetry, cntact cnditins and flw dynamics f the device r material during clinical applicatins
24 Test verview 4/5 Carcingenicity (rdents) -3 (majr prtin f life-span f the test animal; lifetime) (pssible transgenic mdels) determine the tumrigenic ptential frm either single r multiple expsures r cntacts apprpriate fr the rute and duratin f expsure r cntact may be designed t examine bth chrnic txicity and tumrigenicity in a single experimental study, they are anyways very uncmmn in practice as they are nt justified fr material that are gentxic and as they require sham surgery n the cntrl animals. Industry usually prefers t change materials Reprductive and develpmental txicity -3 Evaluate effects n reprductive functin, embrynic develpment (teratgenicity), and prenatal and early pstnatal develpment. cnsidered fr devices/materials used during pregnancy and early infancy r if there is suspect frm the degradatin r leachable studies (example: phthalates) Bidegradatin (in vitr and in viv) -9, specifics in and -15 Fr bidegradable r lng term implanted devices Bidegradatin shuld be simulated in vitr but In viv tests may be necessary fr cmplex device-tissue interactin
25 Test verview 5/5 Txickinetic studies (theretical, in vitr, pssibly in viv) -16 Biresrbable, permanent cntact, with reactive degradatin prductsr leachables evaluate the absrptin, distributin, metablism and excretin (ADME) f a chemical that is knwn t be txic r whse txicity is unknwn. Als determine the delivered dse t the target rgan(s) in rder t assess any health hazards using the physilgically based pharmackinetic (PBPK) mdelling. The extraplatin f test results acrss gender, age, species and dses/expsure may be pssible, The release frm metals, allys and ceramics is usually t lw t justify txickinetic studies, unless the material is designed t bidegrade. Immuntxiclgy -20 immuntxiclgical effects r if the immungenic ptential
26 Interpretatin f results Results are evaluated after apprving: criteria fr determining the acceptability adequacy f the material characterizatin; ratinale fr selectin and/r waiving f tests; Results are apprved by means f: interpretatin f existing data and results f testing; Cmparisn f results fr the device under examinatin t the results fr psitive/ negative cntrls need fr any additinal data t cmplete the bilgical evaluatin; verall bilgical safety cnclusins fr the medical device Impact n risk-benefit rati
CHAPTER 1 INTRODUCTION
CHAPTER 1 INTRODUCTION 1.1 Intrductin t tpic Biavailability is cnsidered t be ne f the mst imprtant pharmackinetic parameters f any drug develped fr extra vascular administratin. Oral biavailability is
More informationCorporate Value Chain (Scope 3) Accounting & Reporting Standard. Summary of Changes
Nvember 2010 Wrld Business Cuncil fr Sustainable Develpment Crprate Value Chain (Scpe 3) Accunting & Reprting Standard Summary f Changes 1. Intrductin This dcument summarizes the changes made t the GHG
More informationAcceptance criteria for process capability indexes generated from statistical tolerance intervals as per ISO
Acceptance criteria fr prcess capability indexes generated frm statistical tlerance intervals as per Backgrund Justificatin fr sampling plans and statistical analysis f results is a requirement fr prcess
More informationSecond Announcement 7 TH INTERNATIONAL WORKSHOP ON GENOTOXICITY TESTING
Secnd Annuncement 7 TH INTERNATIONAL WORKSHOP ON GENOTOXICITY TESTING At the Natinal Cancer Center Research Institute 5-1-1 Tsukiji, Chu-ku Tky, 104-0045 Japan http://www.ncc.g.jp/en/ On 8 th -10 th Nvember
More informationICH Q12 and reduction in post approval complexity Dr Frank Montgomery, Global Head, Reg CMC, AstraZeneca UK EFPIA Expert to ICH Q12 EWG
ICH Q12 and reductin in pst apprval cmplexity Dr Frank Mntgmery, Glbal Head, Reg CMC, AstraZeneca UK EFPIA Expert t ICH Q12 EWG Tpra 2017 Oct 2017 Disclaimer The views presented d nt necessarily reflect
More informationDirectives 90/385/EEC and 93/42/EEC MEDICAL DEVICES. Clinical Evaluation Report Presentation guide
Directives 90/385/EEC and 93/42/EEC MEDICAL DEVICES Clinical Evaluatin Reprt Presentatin guide The elements f the clinical evaluatin reprt are recrds f the prcess that the manufacturer applies t the identificatin,
More informationCharter (draft v0.2) (1)(a) Name. (1)(a) Prepared By. (1)(b) Purpose. (1)(b) Business Problem. Evolution of Product Information
Charter (draft v0.2) Subject: OASIS DITA Pharmaceutical Cntent Subcmmittee DRAFT Charter Date: 21-April-2009 Versin: 0.2 (1)(a) Name Full Name: OASIS DITA Pharmaceutical Cntent Subcmmittee Shrt Name: DITA-PC-SC
More informationIBM Global Services. Server Optimization ... Trends and Value Proposition That Can Drive Efficiencies and Help Businesses Gain A Competitive Edge
IBM Glbal Services Server Optimizatin.......... Trends and Value Prpsitin That Can Drive Efficiencies and Help Businesses Gain A Cmpetitive Edge Intrductin A typical rganizatin s success and ability t
More informationGiovanni Migliaccio Head, Section of Gene and Cell Therapy Istituto Superiore di Sanità
REGULATION (EC) N 1394/2007 Advanced Therapy Medicinal Prducts Givanni Migliacci Head, Sectin f Gene and Cell Therapy Istitut Superire di Sanità Rme Italy REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE
More informationIMI2 PROPOSAL TEMPLATE FIRST STAGE PROPOSAL
IMI2 PROPOSAL TEMPLATE FIRST STAGE PROPOSAL IN TWO-STAGE PROCEDURE (TECHNICAL ANNEX) RESEARCH AND INNOVATION ACTIONS & INNOVATION ACTIONS Nte: This is fr infrmatin nly. The definitive template fr yur call
More informationSiltech Safety Data Sheet Prepared in accordance with GHS standard & Annex II - EC regulation 1907/2006 and amendments
Siltech Safety Data Sheet Prepared in accrdance with GHS standard & Annex II - EC regulatin 1907/2006 and amendments Silube J208-812 Last Revisin Date: Nvember 09, 2012 SDS N: 2527 Material Identificatin:
More informationUDI Compliance Service
UDI Cmpliance Service What is UDI? The US Fd and Drug Administratin (FDA) has issued a ruling that medical devices must cnfrm t a Unique Device Identificatin (UDI) standard. The UK Department f Health
More informationTransforming The Process Industries. RAPID Proposal and Award Process
Transfrming The Prcess Industries RAPID Prpsal and Award Prcess PHASE I: Call fr Prpsals and Prpsal Submissin Opprtunity Annunced. RAPID issued a call fr prject prpsals n August 21 st, 2017 with a clsing
More informationThree priority issues have been identified. They are supported by joint projects presented in more detail online at
JOINT PROJECTS FOCUSED ON THREE ISSUES Under the St. Lawrence Actin Plan 2011 2026, the gvernments f Canada and Quebec cntinue t wrk tgether by pling their expertise and their resurces t prtect and enhance
More informationSiltech Safety Data Sheet Prepared in accordance with GHS standard & Annex II - EC regulation 1907/2006 and amendments
Siltech Safety Data Sheet Prepared in accrdance with GHS standard & Annex II - EC regulatin 1907/2006 and amendments Silmer G-162F Last Revisin Date: June 09, 2014 MSDS N: 6970.1 SECTION 1. IDENTIFICATION
More informationINTERCEPT SURVEY DATA GUIDE JUNE Visitor/Shopper Intercept Survey Data Guide
Visitr/Shpper Intercept Survey Data Guide June 26, 2014 Table f Cntents 1 Intrductin... 3 1.1 Timeline... 3 1.2 Availability f Data... 3 2 Overview... 4 2.1 Summary f Cntents... 4 2.2 Data Dictinary...
More informationPROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregon
PROTOCOL 1850 Millrace Drive, Suite 3A Eugene, Oregn 97403 In-Cell ELISA Supprt Pack Adherent Cell Prtcl MS921 DESCRIPTION This In-Cell ELISA (ICE) Supprt Pack prtcl is fr use with adherent cells. It cntains
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL JOINT RESEARCH CENTRE Directorate B Growth and Innovation Circular Economy and Industrial Leadership
EUROPEAN COMMISSION DIRECTORATE-GENERAL JOINT RESEARCH CENTRE Directrate B Grwth and Innvatin Circular Ecnmy and Industrial Leadership Seville, 6 th April 2018 Level(s) testing phase Guidance and rules
More informationHEALTH AND SAFETY POLICY MISSION STATEMENT
HEALTH AND SAFETY POLICY MISSION STATEMENT IPLOCA is ttally cmmitted t the prmtin f health and safety in all areas f its influence and subscribes t the philsphy that all accidents are preventable. Therefre
More informationThe Well Lifecycle & Data Management
The Well Lifecycle & Data Management PPDM April Lunchen Rbert Lvelace Rbert.Lvelace@sbti.cm 214-870-1235 4/22/13 Agenda Intrductin Well Lifecycle Overview Rle f Data Management Data management impacts
More informationCDM Plan Submission and Review Criteria Rules
Cnservatin First Framewrk LDC Tl Kit Final v4.0 January 17, 2018 CDM Plan Submissin and Review Rules 1) Purpse and definitins 1.1 These Rules set ut: a) the rles, respnsibilities and timing fr CDM Plan
More informationReport on Inspection of PricewaterhouseCoopers LLP (Headquartered in New York, New York) Public Company Accounting Oversight Board
1666 K Street, N.W. Washingtn, DC 20006 Telephne: (202) 207-9100 Facsimile: (202) 862-8433 www.pcabus.rg Reprt n 2014 (Headquartered in New Yrk, New Yrk) Issued by the Public Cmpany Accunting Oversight
More informationMEVION SOURCING STRATEGY SUPPLIER CODE OF CONDUCT
MEVION SOURCING STRATEGY The MEVION S250, while being the mst cmpact prtn therapy system in the wrld, is still a relatively large and cmplex prduct. As such, ur supply chain utilizes a high-mix, lw vlume
More informationRESTRICTED JOB SPECIFICATION. Senior Software Developer
JOB SPECIFICATION FUNCTION JOB TITLE REPORTING TO GRADE WORK PATTERN LOCATION TRAVEL REQUIRED ROLE ID IT & Digital Senir Sftware Develper Develpment Manager Band E Full-time Birmingham Occasinally TBC
More informationRecords Management Policy
Recrds Management Plicy Main Authr: Cnsultatin Rute: Apprved By: Date f Issue: Applicable: Organisatinal wide Versin: 1.0 Review Date: February 2011 Versin 1.0: February 2010 Change Cntrl Versin Change
More informationName Phone Logo. W&RSETA W&RSETA
Occupatinal Qualificatin Dcument Occupatinal Cde Qualificatin Title NQF Level Lg 523101 Occupatinal Certificate: Checkut Operatr 2 Name Email Phne Lg Develpment Quality Partner W&RSETA imarrian@wrseta.rg.za
More informationDepartmental Curriculum Planning
Departmental Curriculum Planning 2014 2015 Department: Business Subject: Vcatinal (BTEC) Business Key Stage: 4 Year Grup: 10 Prgramme f Study Tpic (s) studies Key skills taught / develped / assessed Mdule
More informationo Mitigation measures are required to be identified. Soil
Mitigatin measures are required t be identified. Sil Pllutin f sil due t handling, use and strage f hazardus substances during cnstructin and peratin. The lss f available tp sil. Mitigatin measures are
More informationBest Practice Checklist for EPC
Best Practice Checklist fr EPC / A Definitins, interpretatin Technical aspect & what t lk fr in the EPC cntract 1. Is there a set f definitins f imprtant terms prvided and are thse clear and understd by
More informationDATE FOR COMING INTO EFFECT 1 April 2014*
Lndn, 24 March 2014 EMA/14522/2007-Rev.1 The Revised Checking Prcess f Mck-Ups and Specimens f uter/immediate labelling and package leaflets in the Centralised Prcedure fr Veterinary Medicinal Prducts
More information2014 Water Quality Report for Harbor Beach Water Treatment Plant
This reprt cvers the drinking water quality fr the Harbr Beach Water Treatment Plant fr the calendar year 2014. This infrmatin is a snapsht f the quality f the water prvided t yu in 2014. Included are
More informationEMISSION REDUCTIONS UNDER CAP-AND-TRADE PROPOSALS IN
EMISSION REDUCTIONS UNDER CAP-AND-TRADE PROPOSALS IN THE 111 TH CONGRESS Jhn Larsen and Rbert Heilmayr June 25, 2009 This analysis prvides an assessment f reductins in greenhuse gas (GHG) emissins relative
More informationA Risk-Based Approach to Setting Sterile Filtration Bioburden Limits
EBE Psitin Paper Draft: Final: Authr: EBE BiManufacturing WG Date: 13/09/2016 EBE Psitin Paper: A Risk-Based Apprach t Setting Sterile Filtratin Biburden Limits Executive Summary The ratinale behind the
More informationChapter 1: Purchasing & Supply Management January :10 PM
Chapter 1: Purchasing & Supply Management January-10-13 1:10 PM Crprate Supply Challenges Opprtunities Increased utsurcing --> suppliers need t respnd t end-custmer's needs Dependence n supplier's respnsibility
More informationRegulations Amending the Food and Drug Regulations (1475 Good Manufacturing Practices)
Canada Gazette: Vl. 147, N. 10 May 8, 2013 Registratin SOR/2013-74 April 26, 2013 FOOD AND DRUGS ACT Regulatins Amending the Fd and Drug Regulatins (1475 Gd Manufacturing Practices) P.C. 2013-420 April
More informationNotes and guidance: Paper 1 Section B Poetic voices
Ntes and guidance: Paper 1 Sectin B Petic vices This resurce explains hw the questin in the specimen assessment materials fr AS Paper 1, Sectin B, Petic vices, addresses the assessment bjectives, with
More informationHeparin: Therapeutic Unfractionated Heparin (UFH) Infusion Procedure
Prcedure Heparin: Therapeutic Unfractinated Heparin (UFH) Infusin Prcedure 1. Purpse This dcument utlines the prcedure details fr the cmmencement and maintenance f unfractinated heparin (UFH) infusins
More informationYale Shared Services. Benefits of Creating a Purchase Order: Procure to Pay Tool Kit
Prcure t Pay Tl Kit Benefits f Creating a Purchase Order: Priritized cntract pricing Upfrnt charging validatin Cmmitment is made Details f gds and services prvided Terms and Cnditins are met Wrkflw f payment
More informationIESBA Meeting (March 2013) Agenda Item
Agenda Item 7-A Backgrund Lng Assciatin f Senir Persnnel (Including Partner Rtatin) with an Audit Client Matters fr Cnsideratin 1. Paragraph 290.150 f the IESBA Cde f Ethics fr Prfessinal Accuntants (the
More informationSafety and Security Checks for Tank Container HSE CoP 613. Safety and Security Checks for Tank Container. HSE Code of Practice 613
Safety and Security Checks fr Tank Cntainer HSE Cde f Practice 613 Table f Cntents 1. Purpse... 3 2. Definitins... 3 3. Scpe... 3 4. Mandatry principles r standards... 3 4.1 Legal... 4 4.2 Prcess requirements...
More informationOP 1: Greenhouse Gas Emissions
OP 1: Greenhuse Gas Emissins 10 pints available A. Credit Ratinale This credit recgnizes institutins that have inventried their greenhuse gas (GHG) emissins and that have reduced their adjusted net Scpe
More informationProposed EASR Regulation Standard Systems and Equipment. AWMA Breakfast Sessions Fall 2013
Prpsed EASR Regulatin Standard Systems and Equipment AWMA Breakfast Sessins Fall 2013 What This Presentatin Will Cver New prpsed activities t be added t the EASR Prpsed exemptins t be added t O. Reg. 524/98
More informationAdult Mosquito Control Pesticide We Use Synthetic Pyrethroids(Pyrethrum)
Adult Msquit Cntrl Pesticide We Use Synthetic Pyrethrids(Pyrethrum) Fr truck munted grund spraying the City f Ennis Department f Health Services uses a prduct called Aqualuer 20-20, a water-sluble synthetic
More information9707 BUSINESS STUDIES
CAMBRIDGE INTERNATIONAL EXAMINATIONS GCE Advanced MARK SCHEME fr the May/June 2014 series 9707 BUSINESS STUDIES 9707/31 Paper 3 (Case Study), maximum raw mark 100 This mark scheme is published as an aid
More informationRequest for Proposal
Request fr Prpsal DMDII-17-02 Advanced Analytics fr Supply Chain Operatins Technlgy Thrust Area: Agile, Resilient Supply Chain Revisin 1.0 Release Date: 4 August 2017 POC: Sctt Kruse Prject Innvatin Engineer
More informationPlanning Considerations to Avoid Issues and Risks in Adverse Situations
Planning Cnsideratins t Avid Issues and Risks in Adverse Situatins Abstract Authr - Preeti Jain Mishra, PMP C Authr - Swadhin Mishra, PMP A prject with 6 resurces and 3 mnths strict schedule, and tw resurces
More informationInterstate 91 Viaduct Study MassDOT Contract No Public Involvement Plan
Interstate 91 Viaduct Study MassDOT Cntract N. 82617 Public Invlvement Plan Prject Overview and Gals The prtin f Interstate 91 (I-91) between State Street and the interchange with I-291 parallels the Cnnecticut
More informationNZATD Education Trust Awards elearning Award Guidelines for Entrants
NZATD Educatin Trust Awards elearning Award Guidelines fr Entrants Fcus f Award NZATD intrduced this award t recgnise excellence in the design and implementatin f elearning initiatives within rganisatins.
More informationUniversity of Adelaide Induction Framework
University f Adelaide Inductin Framewrk Inductin at the University f Adelaide Inductin is the prcess thrugh which new staff members are welcmed t the University and prvided with the essential infrmatin
More informationThe Safety Case for Transporting Spent Nuclear Fuel
The Safety Case fr Transprting Spent Nuclear Fuel Charles Krs 1, Dr Ruth Weiner 2 1 NECSA, PO Bx 582, Pretria, 0001, Suth Africa 2 Sandia Natinal Labratries, PO Bx 5800, MS 0718 Albuquerque, NM, 87105-0718,
More informationInventory Control Models Chapter 6
Lecture 9 Intrductin Inventry Cntrl Mdels Chapter 6 T accmpany uantitative Analysis fr Management, Eleventh Editin, by Render, Stair, and Hanna n Inventry is an expensive and imprtant asset t many cmpanies.
More information2. HAZARDS IDENTIFICATION. Contact with eyes may cause irritation. Prolonged skin contact may cause skin irritation.
Distributed by: 14400 Lmitas Ave City f Industry, CA 91746 1-800-4Laguna inf@lagunaclay.cm WNW.lagunaclay.cm MATERIAL SAFETY DATA SHEET FEAAO Ferr Crpratin 4150 East 56th Street Cleveland, Ohi 44105 USA
More informationAPPLICABLE TO ALL DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES OF THE COMPANY
APPLICABLE TO ALL DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES OF THE COMPANY PHILOSOPHY JSAW is a prfessinally managed rganisatin and the cre value underlying ur crprate philsphy is "trusteeship". We believe
More informationEmpowered Workgroups. A process area at Level 4: Predictable
Empwered Wrkgrups A prcess area at Level 4: Predictable Purpse Descriptin The purpse f Empwered Wrkgrups is t invest wrkgrups with the respnsibility and authrity fr determining hw t cnduct their business
More informationMedicines, Public Health & the Media
Medicines, Public Health & the Media Brussels, 18.11.2014 Bilgical Standardisatin (OMCL) Geneviève Waeterls, Head f Unit Operatinal Directin «Expertise, Service Prvisin & Custmer Relatins» Rue Juliette
More informationTechnical Mathematics in Air Conditioning and Refrigeration. Air Conditioning, Welding and Water Technologies Department. o Work Experience, General
SECTION A - Curse Infrmatin 1. Curse ID: 2. Curse Title: 3. Divisin: 4. Department: AIRC 10 Technical Mathematics in Air Cnditining and Refrigeratin Technlgy and Health Divisin Air Cnditining, Welding
More information2. HAZARDS IDENTIFICATION
Distributed by: 14400 Lmitas Ave City f Industry, CA 91746 1-800-4Laguna inf@lagunaclay.cm www.lagunaclay.cm MATERIAL SAFETY DATA SHEET ~FERRO Ferr Crpratin 4150 East 56th Street Cleveland, Ohi 44105 USA
More informationUser Applied Labelling of Injectable Medicines, Fluids and Lines Policy
Department f Health and Human Services SYSTEM PURCHASING AND PERFORMANCE - MEDICATION STRATEGY AND REFORM User Applied Labelling f Injectable Medicines, Fluids and Lines Plicy SDMS Id Number: Effective
More informationReregistration of voluntarily deregistered CDM project activities
Paragraph 4 f the anntated agenda, Annex 1 Reregistratin f vluntarily deregistered CDM prject activities CDM EB 87 Paris, France, 23 27 Nvember 2015 UNFCCC Secretariat SDM prgramme Prcedural backgrund
More informationDown Under. Project Management Essential in Process Management Projects
A BPTrends Clumn Dwn Under December 2007 Jhn Jestn & Jhan Nelis BPM Cnsultants, Sydney Australia Authrs: Business Prcess Management Practical Guidelines t Successful Implementatins jhn.jestn@managementbyprcess.cm
More informationCOUNTRY REPORT: Germany
COUNTRY REPORT: Germany Prepared by: ITW Sebastian Bnk Versin 1.1 Date: 10.09.2010 Address: Pfaffenwaldring 6, 70550 Stuttgart, Germany Tel. : +49 (0)711/685-63595 Fax : +49 (0)711/685-63503 E-mail: bnk@itw.uni-stuttgart.de
More informationDelivering World Class Support Services
The Cmpass Service Framewrk Delivering Wrld Class Supprt Services Our Standard Operating Platfrm The Cmpass Service Framewrk (CSF) is ur Standard Operating platfrm develped t deliver high quality and efficient
More informationHeat Pump KEYMARK. Date Description of modification Revision number Initial version 1
Page: 1 f 26 Date Descriptin f mdificatin Revisin number 14-12-2015 Initial versin 1 10/03/2017 Additin f air/air Editrial changes Annex E included in reference t pren12102-2 suppressed Reference t EN
More informationPosition paper on preferred dosage forms to be included in a Model Essential Medicines List for Children
Psitin paper n preferred dsage frms t be included in a Mdel Essential Medicines List fr Children Intrductin The reprt n the 4 th Mdel List f Essential Drugs includes guidelines fr the selectin f pharmaceutical
More informationDigital Advisory Services Professional Service Description Software Defined Networking Strategy and Roadmap
Digital Advisry Services Prfessinal Service Descriptin Sftware Defined Netwrking Strategy and Radmap 1. Descriptin f Services. 1.1 Sftware Defined Netwrking Strategy and Radmap. Verizn will prvide Sftware
More informationFort McMurray Burned and Unburned Soil Samples
Frt McMurray Burned and Unburned Sil Samples The analysis in this dcument was cnducted using publically available test results frm sil samples cllected in the weeks fllwing the Frt McMurray wildfire. These
More informationAvailable online at Energy Procedia 1 (2009) (2008) GHGT-9
Available nline at www.sciencedirect.cm Energy Prcedia 1 (2009) (2008) 2857 2861 000 000 Energy Prcedia www.elsevier.cm/lcate/prcedia www.elsevier.cm/lcate/xxx GHGT-9 Implementing CCS in Eurpe: ZEP s Visin
More informationCritical STAT Questions DoD Leadership Should Ask:
Critical STAT Questins DD Leadership Shuld Ask: Injecting Rigr int the Test and Evaluatin Prcess thrugh Effective Inquiry Authred by: Jennifer Kensler, PhD Francisc Ortiz, PhD Lenny Truett, PhD Jim Crdeir,
More informationCreative Specification Linear VPAID
Creative Specificatin Linear VPAID Last Updated Octber 17, 2017 The User Experience User Experience PC Brwse MSN & Games Mbile Brwse Ads-In-Apps Full Screen USER CHOICE USER CHOICE N/A Ad Skipping VPAID
More informationPractical Ways to Improve the Exercise and Documentation of Professional Scepticism in an ISA Audit
Practical Ways t Imprve the Exercise and Dcumentatin f Prfessinal Scepticism in an ISA Audit May 2013 This paper was prepared by Auditing and Assurance staff at the Chartered Prfessinal Accuntants f Canada
More informationCHAPTER 2: Identifying and Selecting Projects
SOLUTIONS MANUAL FOR SUCCESSFUL PROJECT MANAGEMENT 6TH EDITION BY JACK GIDO, JIM CLEMENTS Successful Prject Management 6th Editin Gid Slutins Manual Cmpleted dwnlad: https://testbankreal.cm/dwnlad/successful-prject-management-6theditin-slutins-manual-gid-clements/
More informationAIM BRIEFING PAPER CONSIGNMENT STOCK APRIL 2011 ASSOCIATION DES INDUSTRIES DE MARQUE EUROPEAN BRANDS ASSOCIATION EUROPÄISCHER MARKENVERBAND
ASSOCIATION DES INDUSTRIES DE MARQUE EUROPEAN BRANDS ASSOCIATION EUROPÄISCHER MARKENVERBAND AIM BRIEFING PAPER CONSIGNMENT STOCK APRIL 2011 9 AVENUE DES GAULOIS B-1040 BRUSSELS BELGIUM TEL +322 7360305
More informationQualified Persons involved in the manufacture of pharmaceuticals Study Guide
Qualified Persns invlved in the manufacture f pharmaceuticals Study Guide The knwledge and practical experience required by Qualified Persns invlved in the manufacture f pharmaceuticals in the UK February
More informationCertificate in Construction Project Management
Certificate in Cnstructin Prject Management Duratin: 6 Mnths Distance Learning Prgramme Language: English RICS Member: 895.00 + VAT Nn RICS Member 1075.00 + VAT Curse Summary This prgramme explres the
More informationModel Risk Management
Mdel Risk Management May 2013 Crwe Hrwath LLP is an independent member f Crwe Hrwath Internatinal, a Swiss verein. Each member firm f Crwe Hrwath Internatinal is a separate and independent legal entity.
More informationSample Cytotoxicity Assay Protocol
Sample Cyttxicity Assay Prtcl Plating (Example) Day 1: Plate cells at 2500 cells/well fr a typical 3- plate cyttxicity assay: Cells shuld be lifted frm the flask (if need be) and cunted. Only the center
More informationReport on Inspection of Grant Thornton LLP (Headquartered in Chicago, Illinois) Public Company Accounting Oversight Board
1666 K Street, N.W. Washingtn, DC 20006 Telephne: (202) 207-9100 Facsimile: (202) 862-8433 www.pcabus.rg Reprt n 2013 (Headquartered in Chicag, Illinis) Issued by the Public Cmpany Accunting Oversight
More informationRisk Assessment and Integrity Management of Three Cross-Lake Pipelines
Abstract: Risk Assessment and Integrity Management f Three Crss-Lake Pipelines Fr the first time in Iran, a Pipeline Integrity Management (PIM) Prgram was develped fr a set f crss-lake pipelines in Khuzistan
More informationMaking the move from Sage Abra Suite (FoxPro) to Sage HRMS (SQL)
Making the mve frm Sage Abra Suite (FxPr) t Sage HRMS (SQL) 5272 S. LEWIS, SUITE 100 TULSA, OK 74105 918.496.1600 TOLL FREE: 877.496.1600 Making the mve frm Sage Abra Suite (FxPr) t Sage HRMS (SQL) As
More informationSAFETY DATA SHEET (SDS)
Page 1/7 SAFETY DATA SHEET (SDS) SECTION I PRODUCT AND MANUFACTURER INFORMATION Prduct Name: Chemical Systems: Sizes: Designed fr Recharge: NiCd Rechargeable Battery Nickel-Cadmium All Yes Cmpany Infrmatin:
More informationTOWN OF PAYSON WATER DEPARTMENT BACKFLOW PREVENTION PROGRAM CUSTOMER INFORMATION PACKAGE
TOWN OF PAYSON WATER DEPARTMENT BACKFLOW PREVENTION PROGRAM CUSTOMER INFORMATION PACKAGE TOWN OF PAYSON Backflw Preventin Prgram Develpers, Cntractrs and Paysn Residents: An apprved backflw preventin assembly
More informationPATH Program HMIS MANUAL
PATH Prgram HMIS MANUAL A Guide fr HMIS Users and System Administratrs Released Nvember 2017 U.S. Department f Husing and Urban Develpment 2017 Versin 1.1 Cntents Release & Update Infrmatin... 1 Intrductin...
More informationRoot Cause Analysis Tool (RCAT): An Old Tool with a Critical New Twist for Better Prevention AND Safety Culture
Rt Cause Analysis Tl (RCAT): An Old Tl with a Critical New Twist fr Better Preventin AND Safety Culture Cathy A. Hansell, SMS, CSM, CCSR, MS, JD www.breakthrughresults.rg; chansell@breakthrughresults.rg
More informationDi(2-ethylhexyl) terephthalate (DEHT) (CAS # ) GreenScreen Assessment. October 11 th, 2012
Di(2-ethylhexyl) terephthalate (DEHT) (CAS #6422-86-2) GreenScreen Assessment Octber 11 th, 2012 1367 Cnnecticut Ave., N.W., Suite 300 Washingtn, D.C. 20036 TABLE OF CONTENTS GreenScreen Summary Rating
More informationMICROBIAL CONTAMINATION CONTROL A HOLISTIC APPROACH. Sponsored by Prudential Cleanroom Supplies and VWR
Micrrite, Inc. brings yu this unique advanced curse in Micrbial Cntaminatin Cntrl; part f Micrrite s Practical Series Seminars MICROBIAL CONTAMINATION CONTROL Spnsred by Prudential Cleanrm Supplies and
More informationTechnical Welding. Course Design EASTERN ARIZONA COLLEGE Industrial Technology Education. Technical Welding
Curse Infrmatin Organizatin Divisin Curse Number MSP 210 Title Credits 2 Develped by Lecture/Lab Rati Transfer Status Activity Curse Technical Welding Curse Design 2005-2006 EASTERN ARIZONA COLLEGE Industrial
More informationRomanian Emergency Management Information System Architecture
Rmanian Emergency Management Infrmatin System Architecture Intrductin Rmanian is a fully integrated infrmatin system cnnecting all EOCs and thers stakehlders fr streamlining infrmatin sharing and decisin
More informationINVENTION DISCLOSURE
1. Inventin Title. efridge: The smart kitchen s hub 2. Inventin Summary. This inventin describes a smart refrigeratr (r efridge ) that acts as the hub f a smart kitchen ec-system, a methd fr prviding infrmatin
More informationIn this fact sheet we answer the four most common questions new clients ask:
Wrking With Federal Prpsals Intrductin In this fact sheet we answer the fur mst cmmn questins new clients ask: What tasks d yu perfrm and what d yu need frm us? Hw d we use the Virtual War Rms? Hw much
More informationSection III: REGULATORY FRAMEWORK
Sectin III: REGULATORY FRAMEWORK A. THE LABORATORY SAFETY STANDARD 1. Backgrund 2 2. Applicability 2 3. Summary f Standard 3 B. THE LABORATORY SAFETY STANDARD AT UCSB 1. Intrductin 4 2. Respnsibilities
More informationPEPA CHECKLIST FOR WASTE MANAGEMENT INFRASTRUCTURE TO ASSESS THE STATUS OF PLANNING/PROGRAMMING OF THE PROJECT PIPELINE
_ PEPA CHECKLIST FOR WASTE MAAGEMET IFRASTRUCTURE TO ASSESS THE STATUS OF PLAIG/PROGRAMMIG OF THE PROJECT PIPELIE te: The starting pint fr an accessin-driven envirnmental investment prgramme is a systematic
More informationWeb InfoPLU$ Account Transfer USER GUIDE
Web InfPLU$ Accunt Transfer USER GUIDE Fr infrmatinal purpses nly, nt cnsidered an advertisement. Web InfPLU$ Accunt Transfer USER GUIDE TABLE OF CONTENTS ACCOUNT TRANSFER... 2 ACCOUNT TRANSFER SUMMARY...
More informationCMC outsourcing in small virtual biotech company
Arming the patient s immune system t fight cancer CMC utsurcing in small virtual bitech cmpany 28.02.2018 Subjects Intrductin t Targvax and technlgy platfrms Outsurcing t CDMOs Selectin f CDMO 2 Subjects
More informationCourse manual Master s Thesis Innovation Sciences
Curse manual Master s Thesis Innvatin Sciences 2014-2015 Curse Cde: GEO4-2239X Credits: 45 EC Crdinatr Dr. Frank J. van Rijnsever, e-mail: f.j.vanrijnsever@uu.nl, phne: 030 253 7484 Lecturers and tpics
More informationVerification Summary Report (VSR) Instructions
Verificatin Summary Reprt (VSR) Instructins The verificatin prcess must be dne at the spnsr (district) level. Accessing the VSR Lg int IWAS; Click n System Listing n the left side f the screen; Click n
More information1. Elements of an Integrated Report 1.1 Organizational overview and external environment
Pg Ref Marks 1. Elements f an Integrated Reprt 1.1 Organizatinal verview and external envirnment An integrated reprt shuld disclse the main activities f the rganizatin and the envirnment f which it perates.
More informationProject Status Report
Prject Status Reprt Fr perid: March 2007 Defining and Delivering a Service Level Agreement Submitted by: Ann Berry-Kline Distributin: ITSMG Status Item Current Status Prir Status Status Ntes: Overall Prject
More informationAFMA MODEL FARMERS MARKET RULES AND GUIDELINES
Mdel Rules AFMA MODEL FARMERS MARKET RULES AND GUIDELINES These mdel Farmers Market Rules and Guidelines have been develped by AFMA fr use as a template in establishing new Farmers Markets thrughut Australia
More informationExecutive Summary European Union s General Data Protection Regulation (EU GDPR) January 2018
Executive Summary Eurpean Unin s General Data Prtectin Regulatin (EU GDPR) January 2018 Legal Disclaimer The infrmatin in this presentatin is cnfidential and prprietary t SAP and may nt be disclsed withut
More informationIn this Document: EMV 3-D Secure General and Testing FAQs. EMV 3-D Secure General FAQs
In this Dcument: EMV 3-D Secure General and Testing FAQs 1. What is EMV 3-D Secure? EMV 3-D Secure General FAQs EMV Three-Dmain Secure (3DS) is a messaging prtcl develped by EMVC t enable cnsumers t authenticate
More information